4 directorsHidden nameVisible after signing in and 3 others
Owners
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Gross margin from €40,225 to €72,669Loss of €284,346Capital increase of €99,993.6008-12Equity from €548,451 to €364,098Debts from €73,163 to €575,002Investments €376,322
Lower net result than 95% of companies in computer programming and consultancy. The sector median is €28,020, over 22,108 companies.
Total assets +51%: capital increase
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 3,235 companies had the same profile as RheumaFinder has now. Each dot stands for 9 companies, two years later.
87.5%
were still trading
8.9%
stopped another way
3.4%
went bankrupt
Micro
2 to 5 years old
solvency 30% or more
a loss of 10% of the balance sheet or more
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,235 companies, not a prediction for RheumaFinder. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Board and ownership
Name hiddenVisible after signing in
Director, since 11-05-2023
Hidden nameVisible after signing in
Director, since 11-05-2023
Name after signing inVisible after signing in
Director, Name hiddenVisible after signing in, since 15-12-2023
Hidden nameVisible after signing in
Director, since 26-11-2025
Name after signing inVisible after signing in 27.69%score XXVisible after signing inequity €16.1m (2025) · annual accounts 2025 of Hidden nameVisible after signing in
Capital increase of €199,987.20
13,888 new shares · General meeting of 17-04-2026 · Gazette deed
Capital increase of €99,993.60
6,944 new shares · Name after signing inVisible after signing in, Name hiddenVisible after signing in, Hidden nameVisible after signing in and Name after signing inVisible after signing in resign · Name hiddenVisible after signing in, Hidden nameVisible after signing in and Name after signing inVisible after signing in act as permanent representatives · General meeting of 26-11-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0801688964
Capital contribution of €274,996
General meeting of 14-10-2024 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as RheumaFinder: computer programming (NACE 62100). They are comparable in size and age: total assets between €696,000 and €1.5m, founded between 2022 and 2023.
The annual accounts of RheumaFinder for financial year 2025 show a net loss of 52% of the equity at the start of that year. The 2025 annual accounts show equity of €364,098 and a net result of -€284,346.
Its solvency ranks better than 33% of 22,103 sector peers (NACE 62) in financial year 2025. The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
According to the KBO register, the main activity is computer programming (NACE 62100).
What is the legal form of RheumaFinder?
RheumaFinder is a private limited company (BV).
When was RheumaFinder founded?
RheumaFinder was founded on 11-05-2023.
Is RheumaFinder still active?
Yes, RheumaFinder is an active enterprise in the KBO register.
How many employees does RheumaFinder have?
RheumaFinder had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does RheumaFinder fall under?
In its 2024 annual accounts, RheumaFinder states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of RheumaFinder?
The turnover in financial year 2025 is about €170,000. This figure is estimated from the gross margin of €72,669 and 30 comparable companies (NACE 62100). It probably lies between €140,000 and €190,000.
Is RheumaFinder profitable?
In financial year 2025, RheumaFinder made a loss of €284,346.
Where can I find the annual accounts of RheumaFinder?
RheumaFinder filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RheumaFinder due?
RheumaFinder must file the annual accounts for financial year 2026 by 31-07-2027.Timeline